These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27766369)

  • 21. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.
    Clout A; Narayanasamy N; Harris I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Sydney AFF Score: A Simple Tool to Distinguish Females Presenting With Atypical Femur Fractures Versus Typical Femur Fractures.
    Crouch G; Dhanekula ND; Byth K; Burn E; Lau SL; Nairn L; Nery L; Doyle J; Graham E; Ellis A; Clifton-Bligh RJ; Girgis CM
    J Bone Miner Res; 2021 May; 36(5):910-920. PubMed ID: 33528853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
    Favinger JL; Hippe D; Ha AS
    Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.
    Bissonnette L; April PM; Dumais R; Boire G; Roux S
    Bone; 2013 Oct; 56(2):406-9. PubMed ID: 23871749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty.
    Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH
    Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in "typical" atypical subtrochanteric femoral fracture: A proposed theory of atypical femoral fracture subtypes.
    Oh Y; Yamamoto K; Hashimoto J; Fujita K; Yoshii T; Fukushima K; Kurosa Y; Wakabayashi Y; Kitagawa M; Okawa A
    Bone; 2020 Aug; 137():115453. PubMed ID: 32470545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral atypical femoral fractures: how much symmetry is there on imaging?
    Probyn L; Cheung AM; Lang C; Lenchik L; Adachi JD; Khan A; Josse RG; Tomlinson G; Bleakney R
    Skeletal Radiol; 2015 Nov; 44(11):1579-84. PubMed ID: 26169723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying atypical femoral fractures--a retrospective review.
    Juby AG; Crowther S; Cree M
    Calcif Tissue Int; 2014 Nov; 95(5):405-12. PubMed ID: 25209972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiographic features of multifocal endosteal thickening of the femur in patients on long-term bisphosphonate therapy.
    Mohan PC; Howe TS; Koh JS; Png MA
    Eur Radiol; 2013 Jan; 23(1):222-7. PubMed ID: 22814830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
    La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
    AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Gu KD; Ettinger B; Grimsrud CD; Lo JC
    Osteoporos Int; 2021 Oct; 32(10):2119-2123. PubMed ID: 33914104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with atypical femoral fracture.
    Kim D; Sung YK; Cho SK; Han M; Kim YS
    Rheumatol Int; 2016 Jan; 36(1):65-71. PubMed ID: 26202894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized cortical thickening of the femoral diaphysis captured on an X-ray before alendronate therapy in two cases of atypical femoral fracture.
    Iizuka Y; Takechi R; Iizuka H; Omodaka T; Takagishi K
    Skeletal Radiol; 2016 Oct; 45(10):1403-7. PubMed ID: 27402027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peri-implant atypical femoral fracture after nail or plate osteosynthesis.
    Kim JW; Oh CW; Park KH; Oh JK; Yoon YC; Kim JK
    J Orthop Sci; 2022 Jul; 27(4):866-875. PubMed ID: 34052080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
    Genest F; Seefried L
    Osteoporos Int; 2018 Aug; 29(8):1815-1825. PubMed ID: 29774402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.